FDA review clears path for second coronavirus vaccine, this one developed by Moderna
By the end of the week, the US could have 2 #coronavirus vaccines.
An FDA review clears path for the coronavirus vaccine, developed by Moderna. Regulators, who confirmed the vaccine was 94% effective, could authorize it as early as Friday.
Comments